(Q38058730)

27 August 2017

title

The pharmacological management of post-stroke muscle spasticity (English)

1 reference

27 August 2017

1 reference

Abdel Magid O Bakheit

series ordinal

1

1 reference

27 August 2017

publication date

1 December 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

29

1 reference

27 August 2017

issue

12

1 reference

27 August 2017

page(s)

941-947

1 reference

Early development of spasticity following stroke: a prospective, observational trial

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0034-Z

Prevalence of spasticity post stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0034-Z

Four-fold increase in direct costs of stroke survivors with spasticity compared with stroke survivors without spasticity: the first year after the event

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0034-Z

Signs of muscle thixotropy during human ballistic wrist joint movements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0034-Z

Spasticity or reversible muscle hypertonia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0034-Z

Spasticity and bone density after a spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0034-Z

Deep venous thrombosis of the legs after strokes. Part I--incidence and predisposing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0034-Z

Drug treatments for spasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0034-Z

Evidence of tolerance to baclofen in treatment of severe spasticity with intrathecal baclofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0034-Z

Gabapentin: pharmacology and its use in pain management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0034-Z

Pregabalin in the treatment of spasticity: a retrospective case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0034-Z

Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0034-Z

Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0034-Z

Localization of the motor endplate zone in human skeletal muscles of the lower limb: anatomical guidelines for injection with botulinum toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0034-Z

A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0034-Z

Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0034-Z

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0034-Z

Use of botulinum toxin type A in management of adult spasticity--a European consensus statement

21 January 2018

1 reference

12 December 2020

Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity after a Stroke

1 reference

12 December 2020

The mechanism of action of dantrolene sodium

1 reference

12 December 2020

Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study

1 reference

12 December 2020

The mode of action of the gaba derivative baclofen in human spasticy

1 reference

12 December 2020

Gabapentin for the treatment of spasticity in patients with spinal cord injury

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke

1 reference

12 December 2020

Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia

1 reference

12 December 2020

Assessment of anthropometric, systemic, and lifestyle factors influencing bone status in the legs of spinal cord injured individuals

1 reference

12 December 2020

Gabapentin effect on spasticity in multiple sclerosis: a placebo-controlled, randomized trial

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke

1 reference

12 December 2020

Tizanidine: neuropharmacology and mechanism of action

1 reference

12 December 2020

Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm

1 reference

12 December 2020

The effect of total cumulative dose, number of treatment cycles, interval between injections, and length of treatment on the frequency of occurrence of antibodies to botulinum toxin type A in the treatment of muscle spasticity

1 reference

12 December 2020

Research on a technic for measurement of spasticity

1 reference

12 December 2020

Interrater reliability of a modified Ashworth scale of muscle spasticity

1 reference

12 December 2020

10.1007/S40266-012-0034-Z

Identifiers

DOI

1 reference

release_ilq4qmlo7reoxd3ig5ym3nhbje

27 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ilq4qmlo7reoxd3ig5ym3nhbje

24 November 2022

mapped directly with Wikidata item

1 reference